TB-HIV co-infected study participants | |
---|---|
CD4+ T-cell count: no. (%) | 6 (33) |
   CD4+ T-cells/μL: median (range) | 318 (18-739) |
   CD4+ T-cells <200 | 2 |
   CD4+ T-cells 200-350 | 1 |
   CD4+ T-cells >350 | 3 |
   CD4+ T-cells unknown | 12 |
Anti-retroviral therapy: no. (%) | 4/18 (22) |
   Commenced prior to TB diagnosis | 1 |
   Commenced during TB treatment | 1 |
   Commenced after TB treatment completed | 2 |
ART type | Â |
   AZT/3TC/nevirapine | 3 |
   AZT/3TC/efavirenz | 1 |
Co-trimoxazole: no. (%) | 11/18 (61) |